21 April 2021
Cenkos Securities plc
("Cenkos" or the "Company")
EBT Share Purchase Plan
Zedra Trust Company (Guernsey) Limited ("Zedra" or the "Trustee") administers the Cenkos Securities EBT (the "EBT") and as previously announced currently has a trading plan (the "EBT Share Purchase Plan") in place with the Company. To meet the future demands in servicing the Company's share schemes, the limit on monthly purchases being made under the EBT Share Purchase Plan will be £300,000 (previously £200,000). All previous terms and conditions remain the same as previously announced on 4 January 2021 and as detailed below.
Under the EBT Share Purchase Plan, the Trustee has instructed its broker to acquire ordinary shares of 1p each in the Company ("Ordinary Shares") for the EBT. Purchases under the EBT Share Purchase Plan will be limited to £300,000 of Ordinary Shares (by market value) per calendar month and the maximum price paid for such Ordinary Shares shall be an amount equal to the higher of: (i) 5% above the average of the middle market quotations for such Ordinary Shares for the preceding five business days immediately preceding the day on which the purchase is made; (ii) the price of the last independent trade of Ordinary Shares on the venue where the purchase is carried out; and (iii) the highest current independent bid for an Ordinary Share as derived from the trading venue where the purchase is carried out. The EBT Share Purchase Plan will, unless terminated by the Trustee at an earlier date, expire on 31 December 2021.
Zedra, as Trustee of the EBT, has absolute discretion and independence in respect of all trading decisions it may make in respect of the purchase of Ordinary Shares pursuant to the EBT Share Purchase Plan. Zedra currently holds 833,592 unallocated shares (1.47%).
For further information, please contract:
Cenkos Securities plc
Jim Durkin, Chief Executive Officer Tel: 0207 397 8900
SPARK Advisory Partners Limited
Matt Davis, Nominated Adviser Tel: 0203 368 3552
The Nisse Consultancy - Public relations
Jason Nisse Tel: 07769 688618
Andrew Garfield Tel: 07974 982337
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
